Variant report

Variant	nsv1028436
Chromosome Location	chr9:11083426-11098891
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:11064416..11066663-chr9:11091382..11093294,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PTPRD-2	chr9:11097567-11097597	XLOC_007644

Variant related genes	Relation type
CSNK1G2	miRNA target sites

Extended variants
information (count: 765 )
Associated
traits (count: 103 )

Variant overlapped rSNPs/rCNVs (count:765 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs16926916	chr9:11084015-11084016	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs184469656	chr9:11084039-11084040	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs373088357	chr9:11084067-11084068	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs532998434	chr9:11084072-11084073	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs549912496	chr9:11084077-11084078	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs10959519	chr9:11084100-11084101	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs10738213	chr9:11084149-11084150	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs549629397	chr9:11084184-11084185	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs566362824	chr9:11084189-11084190	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs528098987	chr9:11084198-11084199	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs140801427	chr9:11084283-11084284	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs144636525	chr9:11084284-11084285	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs375369351	chr9:11084292-11084293	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs111835572	chr9:11084302-11084303	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs147869674	chr9:11084328-11084329	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs149008588	chr9:11084350-11084351	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs188098979	chr9:11084369-11084370	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs535254635	chr9:11084370-11084371	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs375918212	chr9:11084377-11084378	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs368603398	chr9:11084431-11084432	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs530229689	chr9:11084436-11084437	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs372331420	chr9:11084438-11084439	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs34911081	chr9:11084445-11084446	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs540972464	chr9:11084481-11084482	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs532193482	chr9:11084488-11084489	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs35464944	chr9:11084491-11084492	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs73641369	chr9:11084499-11084500	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs577580898	chr9:11084501-11084502	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs543518018	chr9:11084529-11084530	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs151113258	chr9:11084580-11084581	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs1334047	chr9:11084586-11084587	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs116962977	chr9:11084589-11084590	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs141068305	chr9:11084633-11084634	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs372903508	chr9:11084637-11084638	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs73641370	chr9:11084648-11084649	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs571586185	chr9:11084652-11084653	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs76932962	chr9:11084670-11084671	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs368284921	chr9:11084673-11084674	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs1334049	chr9:11084674-11084675	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs191625694	chr9:11084675-11084676	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs536393287	chr9:11084693-11084694	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs184398763	chr9:11084713-11084714	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs565747036	chr9:11084727-11084728	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs534885083	chr9:11084743-11084744	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs375132045	chr9:11084780-11084781	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs188841150	chr9:11084790-11084791	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs548115768	chr9:11084819-11084820	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs181876700	chr9:11084836-11084837	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs557038489	chr9:11084850-11084851	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs573778054	chr9:11084853-11084854	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:103)

Disease	PMID	Source
abnormal development	18461090	CNVD
Disorders of sex development	21048976	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma	19074898	CNVD
Malignant melanoma	19074898	CNVD
Prostate cancer	16573809	CNVD
Metanephric adenoma	20802469	CNVD
Cancer	20164920	CNVD
Developmental delay	21147756	CNVD
small cell lung cancer	21764851	CNVD
Glioblastoma multiforme	22286061	CNVD
Glioma	17123091	CNVD
Lung cancer	16773561	CNVD
Colorectal cancer	16272173	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Gastric cancer	16891809	CNVD
Mental retardation	17847001	CNVD
Cutaneous squamous cell carcinomas	17420988	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21611746	CNVD
Melanoma	22183965	CNVD
Barrett''s syndrome	19417022	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Bipolar disorder	19114987	CNVD
Melanoma	20688739	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:23 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:11084000-11084200	Enhancers	ES-I3 Cell Line	embryonic stem cell
2	chr9:11084200-11088600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
3	chr9:11085800-11086200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
4	chr9:11086000-11087200	Enhancers	NH-A	brain
5	chr9:11086200-11088000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
6	chr9:11086400-11087200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
7	chr9:11086800-11088000	Enhancers	Placenta Amnion	Placenta Amnion
8	chr9:11087200-11088400	Weak transcription	NH-A	brain
9	chr9:11088000-11088200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
10	chr9:11088000-11088800	Weak transcription	Placenta Amnion	Placenta Amnion
11	chr9:11088200-11088600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
12	chr9:11088600-11089000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
13	chr9:11088600-11089200	Enhancers	ES-I3 Cell Line	embryonic stem cell
14	chr9:11088800-11089000	Enhancers	NH-A	brain
15	chr9:11088800-11089200	Enhancers	HUES48 Cell Line	embryonic stem cell
16	chr9:11088800-11089600	Enhancers	Placenta Amnion	Placenta Amnion
17	chr9:11089200-11093200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
18	chr9:11093200-11093400	Enhancers	iPS-15b Cell Line	embryonic stem cell
19	chr9:11093200-11093600	Enhancers	ES-I3 Cell Line	embryonic stem cell
20	chr9:11093200-11094000	Enhancers	iPS-20b Cell Line	embryonic stem cell
21	chr9:11093600-11097200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
22	chr9:11094000-11094200	Enhancers	iPS-15b Cell Line	embryonic stem cell
23	chr9:11097200-11097600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links